Cargando…

Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness

BACKGROUND: The identification of large‐artery stiffness as a major, independent risk factor for cardiovascular disease–associated morbidity and death has focused attention on identifying therapeutic strategies to combat this disorder. Genetic manipulations that delete or inactivate the translin/tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyoshi, Kei, Fujimori, Tomonari, Fu, Xiuping, Shah, Aparna P., Yamaguchi, Atsushi, Steenbergen, Charles, Santhanam, Lakshmi, Berkowitz, Dan, Tuday, Eric, Baraban, Jay M., Das, Samarjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382090/
https://www.ncbi.nlm.nih.gov/pubmed/37421280
http://dx.doi.org/10.1161/JAHA.122.028421
_version_ 1785080606745427968
author Akiyoshi, Kei
Fujimori, Tomonari
Fu, Xiuping
Shah, Aparna P.
Yamaguchi, Atsushi
Steenbergen, Charles
Santhanam, Lakshmi
Berkowitz, Dan
Tuday, Eric
Baraban, Jay M.
Das, Samarjit
author_facet Akiyoshi, Kei
Fujimori, Tomonari
Fu, Xiuping
Shah, Aparna P.
Yamaguchi, Atsushi
Steenbergen, Charles
Santhanam, Lakshmi
Berkowitz, Dan
Tuday, Eric
Baraban, Jay M.
Das, Samarjit
author_sort Akiyoshi, Kei
collection PubMed
description BACKGROUND: The identification of large‐artery stiffness as a major, independent risk factor for cardiovascular disease–associated morbidity and death has focused attention on identifying therapeutic strategies to combat this disorder. Genetic manipulations that delete or inactivate the translin/trax microRNA‐degrading enzyme confer protection against aortic stiffness induced by chronic ingestion of high‐salt water (4%NaCl in drinking water for 3 weeks) or associated with aging. Therefore, there is heightened interest in identifying interventions capable of inhibiting translin/trax RNase activity, as these may have therapeutic efficacy in large‐artery stiffness. METHODS AND RESULTS: Activation of neuronal adenosine A(2A) receptors (A(2A)Rs) triggers dissociation of trax from its C‐terminus. As A(2A)Rs are expressed by vascular smooth muscle cells (VSMCs), we investigated whether stimulation of A(2A)R on vascular smooth muscle cells promotes the association of translin with trax and, thereby increases translin/trax complex activity. We found that treatment of A7r5 cells with the A(2A)R agonist CGS21680 leads to increased association of trax with translin. Furthermore, this treatment decreases levels of pre‐microRNA‐181b, a target of translin/trax, and those of its downstream product, mature microRNA‐181b. To check whether A(2A)R activation might contribute to high‐salt water–induced aortic stiffening, we assessed the impact of daily treatment with the selective A(2A)R antagonist SCH58261 in this paradigm. We found that this treatment blocked aortic stiffening induced by high‐salt water. Further, we confirmed that the age‐associated decline in aortic pre‐microRNA‐181b/microRNA‐181b levels observed in mice also occurs in humans. CONCLUSIONS: These findings suggest that further studies are warranted to evaluate whether blockade of A(2A)Rs may have therapeutic potential in treating large‐artery stiffness.
format Online
Article
Text
id pubmed-10382090
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103820902023-07-29 Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness Akiyoshi, Kei Fujimori, Tomonari Fu, Xiuping Shah, Aparna P. Yamaguchi, Atsushi Steenbergen, Charles Santhanam, Lakshmi Berkowitz, Dan Tuday, Eric Baraban, Jay M. Das, Samarjit J Am Heart Assoc Original Research BACKGROUND: The identification of large‐artery stiffness as a major, independent risk factor for cardiovascular disease–associated morbidity and death has focused attention on identifying therapeutic strategies to combat this disorder. Genetic manipulations that delete or inactivate the translin/trax microRNA‐degrading enzyme confer protection against aortic stiffness induced by chronic ingestion of high‐salt water (4%NaCl in drinking water for 3 weeks) or associated with aging. Therefore, there is heightened interest in identifying interventions capable of inhibiting translin/trax RNase activity, as these may have therapeutic efficacy in large‐artery stiffness. METHODS AND RESULTS: Activation of neuronal adenosine A(2A) receptors (A(2A)Rs) triggers dissociation of trax from its C‐terminus. As A(2A)Rs are expressed by vascular smooth muscle cells (VSMCs), we investigated whether stimulation of A(2A)R on vascular smooth muscle cells promotes the association of translin with trax and, thereby increases translin/trax complex activity. We found that treatment of A7r5 cells with the A(2A)R agonist CGS21680 leads to increased association of trax with translin. Furthermore, this treatment decreases levels of pre‐microRNA‐181b, a target of translin/trax, and those of its downstream product, mature microRNA‐181b. To check whether A(2A)R activation might contribute to high‐salt water–induced aortic stiffening, we assessed the impact of daily treatment with the selective A(2A)R antagonist SCH58261 in this paradigm. We found that this treatment blocked aortic stiffening induced by high‐salt water. Further, we confirmed that the age‐associated decline in aortic pre‐microRNA‐181b/microRNA‐181b levels observed in mice also occurs in humans. CONCLUSIONS: These findings suggest that further studies are warranted to evaluate whether blockade of A(2A)Rs may have therapeutic potential in treating large‐artery stiffness. John Wiley and Sons Inc. 2023-07-08 /pmc/articles/PMC10382090/ /pubmed/37421280 http://dx.doi.org/10.1161/JAHA.122.028421 Text en © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Akiyoshi, Kei
Fujimori, Tomonari
Fu, Xiuping
Shah, Aparna P.
Yamaguchi, Atsushi
Steenbergen, Charles
Santhanam, Lakshmi
Berkowitz, Dan
Tuday, Eric
Baraban, Jay M.
Das, Samarjit
Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness
title Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness
title_full Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness
title_fullStr Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness
title_full_unstemmed Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness
title_short Adenosine A(2A) Receptor Regulates microRNA‐181b Expression in Aorta: Therapeutic Implications for Large‐Artery Stiffness
title_sort adenosine a(2a) receptor regulates microrna‐181b expression in aorta: therapeutic implications for large‐artery stiffness
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382090/
https://www.ncbi.nlm.nih.gov/pubmed/37421280
http://dx.doi.org/10.1161/JAHA.122.028421
work_keys_str_mv AT akiyoshikei adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT fujimoritomonari adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT fuxiuping adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT shahaparnap adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT yamaguchiatsushi adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT steenbergencharles adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT santhanamlakshmi adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT berkowitzdan adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT tudayeric adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT barabanjaym adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness
AT dassamarjit adenosinea2areceptorregulatesmicrorna181bexpressioninaortatherapeuticimplicationsforlargearterystiffness